Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS’ EQUITY (Tables)

v3.26.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of assumptions
   
Company stock price on valuation date   $ 10.00  
Volatility     143.85%  
Risk free interest rate - 5 years     3.94%  
Risk free interest rate - 10 years     4.43%  
Dividend yield     0.00%  
Schedule of fair values and derived service periods
                   
    Daily VWAP $10   Daily VWAP $15   Daily VWAP $20   Daily VWAP $25   Daily VWAP $30
Fair value - 5 year service period   $ 9.03     $ 9.02     $ 9.02     $ 9.02     $ 9.01  
Derived service period - years     N/A       0.20       0.38       0.56       0.69  
Fair value - 10 year service period   $ 9.82     $ 9.80     $ 9.80     $ 9.80     $ 9.80  
Derived service period - years     N/A       0.20       0.40       0.58       0.73  
Pre-Funded Common Stock Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of warrants activity
                 
    Pre- Funded Common Stock Warrants
    Shares   Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Life in years(1)
  Intrinsic Value
Outstanding at January 1, 2026     3,913,538     $ 0.00002                  
Purchased     2,079,797     $ 0.00001                  
Exercised     (4,339,649 )   $ 0.00001                  
Outstanding at September 30, 2026     1,653,686     $ 0.00002       –     $ 4,977,554  
Exercisable at September 30, 2026     1,653,686     $ 0.00002       –     $ 4,977,554  

 

  (1) Pre-funded warrants expire only upon exercise
Common Stock Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of warrants activity
                 
    Other Common Stock Warrants
    Shares   Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Life in years
  Intrinsic Value
Outstanding at January 1, 2026     1,735,349     $ 47.66                  
Granted/purchased     4,643,487     $ 6.26                  
Expired     (4 )   $ 4,021,920.00                  
Outstanding at September 30, 2026     6,378,832     $ 15.00       4.23     $ –  
Exercisable at September 30, 2026     5,739,549     $ 16.67       3.81     $ –